{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:33:31Z","timestamp":1764401611442},"reference-count":31,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.vaccine.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:42:09Z","timestamp":1376563329000},"page":"4782-4790","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy"],"prefix":"10.1016","volume":"31","author":[{"given":"Mark J.","family":"Abzug","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin Ye","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Borkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen I.","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/597389","article-title":"Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox","volume":"199","author":"Abzug","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","article-title":"Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization","volume":"144","author":"Flannery","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/518149","article-title":"Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine","volume":"44","author":"Albrich","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0b013e328341b7f1","article-title":"The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis","volume":"25","author":"Nunes","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/597388","article-title":"qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination","volume":"199","author":"Madhi","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0035","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine","volume":"25","author":"Madhi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.inf.0000237830.33228.c3","article-title":"Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy","volume":"25","author":"Abzug","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/605448","article-title":"Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy","volume":"200","author":"Abzug","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/jis386","article-title":"Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy","volume":"206","author":"Abzug","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0055","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1016\/j.vaccine.2011.02.089","article-title":"Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose","volume":"29","author":"Klugman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","article-title":"Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant","volume":"184","author":"Wuorimaa","year":"2001","journal-title":"J. Infect. Dis."},{"article-title":"Recommendations to assure the quality, safety, and efficacy of pneumococcal conjugate vaccines","year":"2009","series-title":"60th Meeting of the WHO Expert Committee on Biological Standardization","key":"10.1016\/j.vaccine.2013.08.002_bib0065"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CDLI.12.1.165-170.2005","article-title":"Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection","volume":"12","author":"Tarrago","year":"2005","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.inf.0000160942.84169.14","article-title":"Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children","volume":"24","author":"Madhi","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.88.5.379","article-title":"Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure","volume":"88","author":"McVernon","year":"2003","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0085","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue","volume":"7","author":"O\u2019Brien","year":"2007","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0095","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2249.1999.01077.x","article-title":"Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae","volume":"118","author":"Antttila","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0105","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.vaccine.2011.06.072","article-title":"The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children","volume":"29","author":"Thanee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0110","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.vaccine.2005.06.002","article-title":"Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children","volume":"23","author":"Spoulou","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and\/or 23-valent polysaccharide vaccine among HIV-infected adults","volume":"20","author":"Feikin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0120","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/00002030-200306130-00017","article-title":"Haemophilus influenza type b conjugate vaccine-induced immunological memory in symptomatic HIV-1-infected children","volume":"17","author":"Spoulou","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0125","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archpedi.1996.02170330064011","article-title":"Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenza type b conjugate vaccine","volume":"150","author":"Rutstein","year":"1996","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(07)70242-6","article-title":"The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease","volume":"8","author":"Bliss","year":"2007","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0135","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.4049\/jimmunol.178.12.8212","article-title":"Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease","volume":"178","author":"Hart","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0140","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood-2005-11-013383","article-title":"Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection","volume":"108","author":"Titanji","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0145","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32828642c7","article-title":"Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy","volume":"21","author":"D\u2019Orsogna","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jir316","article-title":"Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection","volume":"204","author":"Iwajomo","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.08.002_bib0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/653704","article-title":"Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants","volume":"202","author":"Madhi","year":"2010","journal-title":"Journal of Infectious Diseases"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T20:26:34Z","timestamp":1596313594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13010864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0264410X13010864"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}